Proton Pump Inhibitors Augment the Risk of Major Adverse Cardiovascular Events and End‐Stage Renal Disease in Patients With Acute Kidney Injury After Temporary Dialysis

Proton pump inhibitors (PPIs) have been reported to increase the risk of acute and chronic renal disease. However, the data are unclear in patients with acute kidney injury (AKI) requiring dialysis (AKI‐D) who are often candidates for PPIs. To investigate this important issue, we identified 26,052 A...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical pharmacology and therapeutics 2020-06, Vol.107 (6), p.1434-1445
Hauptverfasser: Tsai, I‐Jung, Lai, Tai‐Shuan, Shiao, Chih‐Chung, Huang, Tao‐Min, Wang, Chih‐Hsien, Tsao, Chun-Hao, Chen, Liang-Wen, Lin, Yen‐Hung, Chen, Likwang, Wu, Vin‐Cent, Chu, Tzong‐Shinn
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Proton pump inhibitors (PPIs) have been reported to increase the risk of acute and chronic renal disease. However, the data are unclear in patients with acute kidney injury (AKI) requiring dialysis (AKI‐D) who are often candidates for PPIs. To investigate this important issue, we identified 26,052 AKI‐D patients from Taiwan’s National Health Insurance Research Database weaning from dialysis. During a mean follow‐up period of 3.52 years, the PPI users had a higher incidence of end‐stage renal disease (ESRD) than the PPI nonusers (P 
ISSN:0009-9236
1532-6535
DOI:10.1002/cpt.1762